BioSpace News Archive

Sensifree LTD, a medical device company developing advanced patient monitoring solutions, announced the launch of a joint development program supported by the BIRD Foundation, with Cleveland Clinic.

Echosens, a high-technology company offering the FibroScan® portfolio of solutions, is pleased to announce that the latest Baveno VII guidelines fully support the effectiveness of FibroScan technologies for the management of patients with advanced chronic liver disease, providing a powerful level of support for its use among specialists.

Neuromagen Pharma Ltd., a company developing a new class of telomerase-targeting drugs for the treatment of degenerative, and senescence-associated diseases will provide a company overview at the sixteenth annual BIO-Europe Spring® partnering conference which will be held March 28-31, 2022 in a fully digital format.